General COVID Information
Based on assessments from medical experts that infection rates from the Omicron variant will continue to rise substantially with the projected infection peak coming in early to mid-January, and increased stress on the medical system along with elevated pressure on the University’s contact tracing program, testing, isolation housing, and overall staffing due to likely high case counts among employees, the University is delaying the start of Winter Quarter for most schools and divisions by one week—to January 10, 2022. Additionally, the University is moving to a remote-only instructional format for the first two weeks of the quarter. We anticipate a return to in-person instruction in Week 3 of Winter Quarter, beginning on January 24.
The University of Chicago COVID-19 Dashboard provides important information on the status of COVID-19 at the University and the health of the campus community. We will continue to update the dashboard throughout the summer with the number of cases detected through surveillance testing as well as cases reported to the University via C19HealthReport@uchicago.edu.
Yes. For the 2021-22 academic year, weekly COVID-19 testing is required for anyone who is not fully vaccinated and has received an exception to the University’s vaccination requirement. Weekly COVID-19 testing is available to fully vaccinated individuals on a voluntary basis. Testing is also available to individuals who are symptomatic or have been in close contact with someone who has tested positive for COVID-19.
Yes. All reports made to C19HealthReport@uchicago.eduof a UChicago community member who has been exposed to COVID-19 or tested positive are forwarded to the University’s Contact Tracing Team. A Contact Tracer is assigned to interview each individual with confirmed COVID-19 to determine if they have been in close contact with other members of the University community.
It is vitally important for all members of the University community to cooperate with the University’s Contact Tracing Team. Their work has been essential in limiting the spread of COVID-19 on campus.
Any faculty, other academic appointee, postdoctoral researcher, or staff member with a positive result from a test conducted by UChicago Medicine will be informed of their test by UCM, and will be provided with options for follow-up care. Students who test positive will be notified by and can receive follow-up care from UChicago Student Wellness.
Visit the UChicago Forward travel page for the latest information.
University COVID-19 Vaccination-Related Requirements
As part of the University of Chicago’s COVID-19 vaccination requirement, the University is requiring students and employees to receive a COVID-19 booster shot once they are eligible, unless they have an approved exemption.
To meet the booster shot requirement,
- Students who are currently eligible for a booster must, by January 24, 2022, take one of the steps outlined in the student email.
- Employees who are currently eligible for a booster must, by January 31, 2022, take one of the steps outlined in the employee email.
Individuals who are not eligible for a booster as of the deadlines above must become compliant with the requirement within 30 days of becoming eligible.
We encourage everyone to get their COVID-19 booster shot as soon as possible. Visit vaccines.gov to find a nearby authorized provider of vaccine booster shots.
Yes. As announced in May 2021, the University of Chicago requires students to be fully vaccinated against COVID-19 unless they have an approved exemption. You can find information about the University’s vaccination requirement for students here.
The University is requiring students to receive a COVID-19 booster shot once they are eligible, unless they have an approved exemption. Students who are currently eligible for a booster must, by January 24, 2022, take one of the steps outlined in the student email.
Yes. As announced in September 2021, the University of Chicago requires employees to be fully vaccinated against COVID-19 unless they have an approved exemption. You can find information about the University’s vaccination requirement for employees here.
The University is requiring employees to receive a COVID-19 booster shot once they are eligible, unless they have an approved exemption. Employees who are currently eligible for a booster must, by January 31, 2022, take one of the steps outlined in the employee email.
The University encourages everyone to be vaccinated at their earliest opportunity.
- Contractors and Suppliers: The University expects certain University contractors and suppliers working in University facilities to get fully vaccinated against COVID-19 unless they cannot do so because of a medical or religious reason. This has been communicated to the contractors and suppliers with employees working in any University facilities who are subject to this requirement. (“University facilities” include all owned or leased buildings with University offices, laboratories, classrooms, libraries, cafes, residence halls, museums, performance spaces, or other University facility in Hyde Park and the Chicago area, including the Howard T. Ricketts Laboratory in Lemont, Illinois. Excluded from this definition are the National Laboratories and property leased to third parties by the University’s Commercial Real Estate Operations.)
- Visitors: Visitors may be asked to provide proof of full vaccination or a negative COVID-19 test as a condition of admission to certain convenings on and off campus, as may be required by the venue or event organizer.
Any COVID-19 vaccine authorized for use by the United States Food and Drug Administration (FDA) or by the World Health Organization (WHO) will be accepted. For a list of authorized vaccines, see question #5 below.
At this time, the following vaccines have been authorized by the FDA or WHO, under emergency use authorization/listing, or full authorization in the case of Pfizer/BioNTech, and will satisfy the University’s COVID-19 vaccine requirement:
• AstraZeneca (WHO)
• Covishield/Serum Institute of India (WHO)
• Janssen/Johnson & Johnson (FDA)
• Moderna (FDA)
• Pfizer/BioNTech (FDA)
• Sinopharm (WHO)
• Sinovac (WHO)
This list will be updated as other vaccines are authorized.
COVID-19 vaccines and booster shots are available in the U.S. through retail pharmacies and other providers. Because booster shots are being widely distributed, the best way to schedule a booster shot often is through neighborhood pharmacies and other local providers, including locations throughout the Chicago region. You can find a nearby vaccine site by visiting vaccines.gov. Both the COVID-19 vaccine and the flu shot are available at most neighborhood pharmacies.
No. Individual offices should not set up their own processes or ask individuals about their vaccination status.
A limited number of staff will have access to vaccination data to confirm compliance with University requirements designed to help protect the health and safety of our campus and neighboring communities. The information will be maintained in accordance with all applicable laws and public health regulations.
Given the experience of UChicago Student Wellness in the University’s vaccination efforts including its ongoing role in verifying student immunization compliance, Student Wellness will play a lead role in verifying compliance with the University’s vaccine requirement. Individuals’ vaccination data is stored in a HIPAA-compliant medical record system.
The three vaccines that have received either full approval or emergency use authorization (EUA) by the U.S. Food and Drug Administration all have undergone thorough testing for safety and efficacy in large clinical trials. Each trial enrolled between 28,000 and 44,000 people before the vaccines received EUA status. The vaccines were found to be highly efficacious in preventing COVID-19 infections and recent data suggest that a vaccinated individual has a greatly diminished ability to transmit the virus if exposed.
Over 408 million doses of COVID-19 vaccines were administered in the United States from December 14, 2020, through October 18, 2021. Many people have reported only mild side effects and to date, the systems in place to monitor the safety of the vaccines have found that serious side effects are rare. For more information about vaccine safety, visit the CDC’s website.
For individuals who received a two-dose vaccine, we expect the dosing interval to be consistent with CDC guidelines. However, if your dosing interval is outside these recommendations, we still encourage you to submit your documentation. UChicago Student Wellness is coordinating the University-wide vaccination registry processes. Your records will be reviewed by the UChicago Student Wellness medical team, and if there is concern, they will contact you.
Everyone ages 16 and over is now eligible to get a booster shot six months after completing the Pfizer-BioNTech or Moderna vaccine series or two months after receiving Johnson & Johnson’s Janssen vaccine.
Students should refer to the December 30 email from Provost Ka Yee C. Lee and Katie Callow-Wright, Executive Vice President of the University and Chief of Staff in the Office of the President.
Employees should refer to the December 30 email from Provost Ka Yee C. Lee and Katie Callow-Wright, Executive Vice President of the University and Chief of Staff in the Office of the President.
Testing FAQs – General Information
The University’s testing approach includes three programs: (1) Symptomatic & Exposure Testing for individuals who have potential symptoms of COVID-19 or may have been in close contact with a person who has tested positive for COVID-19; (2) A Mandatory Surveillance Testing Program, for University employees and students who are not fully vaccinated and have obtained a vaccination exemption from the University for medical or religious reasons and will be in University facilities in the Chicago area; and (3) A Voluntary Surveillance Testing Program for fully vaccinated members of the University community who will regularly be on the Hyde Park campus or another University facility in the Chicago area.
Systematic, ongoing testing of unvaccinated asymptomatic individuals is designed to help the University understand the prevalence of COVID-19 on campus, isolate those who are positive, and trace close contacts, all of which will help limit the spread of infection on campus.
New for 2021-22: Beginning in Autumn Quarter 2021, the Mandatory and Voluntary Surveillance Testing programs will utilize a saliva-based COVID-19 test. During their visit, participants will be asked to provide 1-2 ml of saliva into a specimen vial. The test is self-performed and free to participants and all costs will be covered by the University.
For the Symptomatic Testing Program administered by UCM and Student Wellness, a PCR nasal swab test will continue to be used. You will need your insurance information available in order to schedule an appointment for symptomatic testing. You will not receive a bill from UCM or pay anything out of pocket when these services are provided. However, your insurance may be responsible for paying whatever is covered under your policy. Therefore, we still require you to provide your insurance information when receiving symptomatic COVID-19 testing-related services.
Saliva-based tests allow for self-collection. Improvements in the accuracy of saliva-based tests make it a good option for asymptomatic surveillance testing.
Participants should refrain from eating, drinking, chewing gum, using tobacco products, or using oral hygiene products for 60 minutes prior to a testing appointment. We recommend drinking water 60 minutes prior to your appointment to ensure your hydration. If the provided saliva sample is determined by the laboratory to be contaminated, then participants will need to return to the test site for another test.
Your entire appointment, including the sample collection process, should take less than 10 minutes to complete.
You should bring your UChicago ID.
Mandatory Surveillance Testing will begin the week of September 13 but may vary depending on your return to campus date, and the enrollment process. The Voluntary Surveillance Testing program is expected to open for applications from new participants in October 2021 with more information provided in September 2021.
Yes. To participate in any of the testing programs you must sign a consent form and a HIPAA authorization, which permit the release of your results to the University and the UCM. Please note: All participants, regardless of whether they signed similar forms for the 2020-21 academic year, must complete new forms for the 2021-22 academic year. Students under the age of 18 will need to have their legal guardian sign their consent form to complete registration.
The consent and HIPAA authorization describe the applicable testing program(s) in which you will enroll – Mandatory Surveillance Testing, Voluntary Surveillance Testing, and/or Symptomatic Testing – and the procedures that you will be required to follow as a participant in those programs. The consent and HIPAA authorization also describe information that is collected about you, with whom that information is shared, and the purposes for which it is used (e.g., contact tracing).
New for 2021-22: Negative results for those in the Mandatory and Voluntary Surveillance Testing programs can be found on the my.WellnessPortal, which is separate from UChicago Medicine’s MyChart. Positive results will also be available on the portal, but you will also be contacted by phone with any positive results as well as next steps.
For those who are tested through the Symptomatic Testing Program administered by UChicago Medicine and Student Wellness, results can be found on your MyChart account and those with positive results will also be contacted by phone with your result as well as next steps. Students will be contacted by UChicago Student Wellness, while all faculty, other academic appointees, postdoctoral researchers, and staff will be contacted by a member of the COVID-19 Testing Program.
Typically, within 48 hours.
For those participating in the Mandatory or Voluntary Surveillance programs, in addition to notification through the my.WellnessPortal, you will be notified by phone by Student Wellness or a COVID-19 Testing Program staff member if you have a positive result and be provided next steps. Additionally, individuals with a positive test result will be contacted by the UChicago Contact Tracing team to help understand the risk of exposure to other individuals.
Individuals under an isolation or quarantine directive should not report for testing in the Mandatory or Voluntary Testing Program for the duration of their isolation or quarantine and for 90 days following the positive test result.
For those participating in the Symptomatic Testing Program, in addition to notification through MyChart, you will be notified by phone if you have a positive result and be provided next steps. Students will be notified by UChicago Student Wellness; all other staff and faculty will be notified by a UCM medical professional or his/her designee.
Any member of the University community living off campus who tests positive or has close contact with a known COVID-19 case will be advised to stay in their home during the period of isolation or quarantine. Students living off campus will also have telehealth access to on-campus physicians at UChicago Student Wellness and receive regular check-ins from our clinical staff.
Any student, faculty member, other academic appointee, postdoctoral researcher, or staff member who receives a positive result from a test conducted through the University testing program will be provided with instructions for follow-up care. Additional Information and resources on COVID-19 benefits can be found on the Human Resources website.
Any member of the University community who receives a positive test result through a clinic, office, or laboratory not affiliated with the University of Chicago must notify C19HealthReport@uchicago.edu of their test result.
The UChicago COVID-19 Testing team, and either UCM or another testing provider engaged by the University, will report your results to the University, which will use the results to regularly appraise the health of our community and adjust plans accordingly. If your test is positive, it will also be reported to the University’s Contact Tracing team. If you are a student, your results will be sent to UChicago Student Wellness so they can help you with any medical needs you may have. UCM or the University will also report results to federal, state, and/or local public health authorities as required by law.
If you are an employee and receive a positive test result, your result, including your name, will be shared with your supervisor. If you are a student and you test positive, your positive test result, including your name, may also be shared with your area Dean of Students and other faculty, other academic appointees, and staff who need to know your identity to assist you while you are required to isolate and make sure you are taking precautions to keep yourself and others healthy. In all circumstances, the University will instruct its personnel to keep your identity confidential to the extent possible. However, there may be cases in which the University determines that it is necessary to disclose your identity to prevent harm to you or others. For example, if you have roommates, the University may also provide your identity to them. The University may also be required by law in some cases to disclose your identity to public health authorities, government agencies, or others. In such cases, the University may disclose your identity as it determines is appropriate. In some cases, even if the University does not reveal your name or other identifying information, others may be able to infer your identity based on the circumstances.
If you are under the age of 18, the University will also contact your parent(s) or legal guardian(s). In that case, the University will disclose your identity and your test results.
No, the University will be utilizing a specially trained team of employees who will complete contact tracing for all reported positive tests occurring within the University community.
You should email C19Testing@uchicago.edu.
Members of the surrounding community who are symptomatic or have been exposed to someone with COVID-19 have access to UCM’s curbside testing program and must provide their insurance information to be scheduled for a screening. You will need to provide your insurance information to schedule a screening. Insurance will be billed; however, there will be no bill from UCM or out of pocket expense even if your insurance does not cover the testing or requires a copay. For additional information please visit the UCM COVID-19 Information and FAQs website.
Regular surveillance testing is one important part of the University’s layers of precautions to limit the potential spread of COVID-19, which have been designed by infectious disease experts at the University of Chicago Medicine. But no single measure alone is sufficient.
That’s why adherence to a layered approach with many precautions is essential. At UChicago, the other layers include enforcing requirements around vaccinations, face coverings, and performing contact tracing as soon as any cases emerge; preparing for isolation needs, including a residence hall staffed and equipped for on-campus isolation housing; performing cleaning in classrooms every day; and other precautions.
Our infectious disease experts have concluded that weekly testing accompanied by swift contact tracing and isolation is the best and most reasonable testing plan for UChicago right now. We will closely monitor the pandemic as it evolves and are prepared to change course if needed, regarding testing or any other aspect of our precautions.
If you are symptomatic, or are exposed to COVID-19, your participation in the Mandatory or Voluntary Surveillance Testing Program will be paused until you are released from quarantine. If you test positive, your participation in the Mandatory Surveillance Testing Program will be paused for 90 days. People who have recovered from COVID-19 often continue to have positive tests even though they are no longer contagious. If you are scheduled to participate in the Mandatory Surveillance Testing Program, and you have tested positive for COVID-19 at any point in the 90 days prior to the day you are scheduled for your first test in the UChicago program, you should provide such evidence to the attention C19Testing@uchicago.edu.
The University can provide testing to members of the UChicago community who require proof of a negative COVID-19 prior to international travel at no cost. Testing is conducted through the UChicago COVID-19 Voluntary Surveillance Testing Program and uses a Nucleic Acid Amplification (NAAT) real-time reverse transcription polymerase chain reaction (RT-PCR) test. Please ensure that this test meets the requirements of your destination.
Testing will take place at the Walker Museum test site, 1115 E. 58th St. Suite 309, on the Hyde Park campus’ main quadrangle. Appointments are available Monday through Friday from 8 a.m. to 4:45 p.m. Test results are available within two days. Individuals should review the testing requirements of their destination to ensure their appointments are within the allowable time frame for testing before travel and allow sufficient time for results to be released. (If the time frame requires you to be tested on a weekend, contact C19Testing@uchicago.edu for assistance.)
Students and employees may schedule appointments via my.WellnessPortal. To request tests for other individuals, such as family members of international students, email C19Testing@uchicago.edu with details of the request. You should also email C19Testing@uchicago.edu if your destination requires additional information (such as your passport number) included with your test result.
Anyone not already enrolled in the UChicago COVID-19 Mandatory or Voluntary Surveillance Testing Programs must complete the voluntary consent form here prior to being tested.
Mandatory Surveillance Testing Program
Members of the Mandatory Surveillance Testing population—members of the campus community who are not fully vaccinated and those living in residence halls—are automatically registered for the testing program but must complete and sign consent and HIPAA authorization forms and sign up for their account in the my.WellnessPortal. These items must be completed prior to moving into the residence hall and arrival on campus.
- For students, staff, and their families moving into the residence halls, you will get tested on your first day of arrival to campus (or shortly thereafter) even if you are fully vaccinated. In some cases, the University may determine that additional ad-hoc testing of on-campus residents is appropriate, such as in connection with events with higher risk of exposure or rising community positivity rates. Individuals will be notified of such additional testing requirements by Housing and Residential Life leadership.
- If you will be in University facilities in the Chicago area at any frequency and you are not fully vaccinated, you will be tested on a weekly basis on a day and at a time you select when registering. You will be able to reschedule your testing day and time in the WellnessPortal, but you must still be tested once each week.
The testing program operates in the Walker Museum, Suite 309, located on the main quadrangle at 1115 E. 58th Street. It will also operate Fridays at Chicago Booth’s downtown Gleacher Center location, in room 101. The Walker Museum test site can be accessed via the ground-level entrance located between Rosenwald Hall and the Walker Museum. Participants can either take the elevator or stairs to the third floor, then turn left and continue down the hallway to enter the test site.
Yes. Participants will schedule a specific day and time to be tested every week when they register through the my.WellnessPortal. Unlike last year, COVID-19 testing appointments will be set for specific times instead of 4-hour testing windows. Participants will be able to change their appointment times and dates via the self-service capabilities in the portal. Please note that if you are unable to be tested at your regular appointment time, your required to contact the testing program team at C19Testing@uchicago.edu or reschedule through the portal, subject to testing program availability.
All testing locations have been carefully reviewed by the University and UCM team taking into consideration proper social distancing, ventilation, and privacy concerns. Specimen collection is expected to take no more than 10 minutes, and proper PPE will be required for the staff at all testing locations, as appropriate.
Testing is required for members of the campus community who are not considered fully vaccinated in addition to those living in residence halls (on an ad hoc basis). If you do not comply with the testing program, you will be subject to disciplinary action up to and including prohibition from accessing campus buildings or any University facility, and/or unpaid leave or termination of employment for employees.
All costs for administering the Mandatory Surveillance Testing Program are covered by the University. All tests are free and insurance information will not be utilized. See below for information regarding the Symptomatic Testing Program.
The test is a self-performed saliva test. Members of the COVID-19 Testing team will assist participants with the sample collection at the testing locations. Samples are transported by a medical courier to the contracted laboratory for processing and reporting of results.
Individuals who miss, or know they will miss, their normal testing appointment should reschedule their appointment in the my.WellnessPortal, taking care to comply with the weekly frequency requirement. Anyone unable to be meet their testing requirements for a specific week should contact C19Testing@uchicago.edu and advise the testing program staff of the situation.
If you test positive, your participation in the Mandatory Surveillance Testing Program will be paused for 90 days. People who have recovered from COVID-19 often continue to have positive tests even though they are no longer contagious. If you are scheduled to participate in the Mandatory Surveillance Testing Program, and you have tested positive for COVID-19 at any point in the 90 days prior to the day you are scheduled for your first test in the UChicago program, you should provide such evidence to the attention C19Testing@uchicago.edu.
Members of the campus community who are considered fully vaccinated, as long as they do not live in University Housing may opt out of the Mandatory Surveillance Testing programs once they are considered fully vaccinated. Individuals are considered fully vaccinated two weeks after a two-dose vaccine or two weeks after a one-dose vaccine.
Note: if you are fully vaccinated and receive a positive test result, isolation requirements according to public health guidance will continue to apply regardless of your vaccination status. If you think you are considered fully vaccinated based on the information above, do not live in University Housing, and would like to opt-out of the Mandatory Testing Program, contact C19Testing@uchicago.edu.
Voluntary Surveillance Testing Program
University students, faculty, other academic appointee, postdoctoral researchers, and staff members who meet the following criteria qualify
- Are fully vaccinated;
- Will regularly be on the Hyde Park campus or another Chicago-area facility this Autumn Quarter*;
- Has not tested positive for COVID-19 in the 90 days prior to your registration; and
- Can commit to weekly testing for the duration of the Autumn Quarter*.
*Those who intend to leave Chicago for breaks/holidays are eligible to participate in the testing program.
Please note: This program is distinct from the Mandatory Surveillance Testing Program, which is required for all employees and students who are not yet fully vaccinated or have obtained a vaccination exemption from the University for medical or religious reasons.
Cases of COVID-19 are possible, even among those who are fully vaccinated. Weekly voluntary testing for employees and students who are fully vaccinated and will be on campus or another Chicago-area University facility regularly this Autumn Quarter can serve as an additional individual precaution and will help us monitor and limit the spread of COVID-19 on campus.
The Voluntary Surveillance Testing program is expected to start in October 2021, with the opportunity to apply starting in late September 2021.
A email was sent to members of the University community on September 30 with application details, and you can also find instructions on the testing area of the UChicago Forward website. You can apply to participate until 5 p.m. CT on Thursday, October 7, or until it has reached capacity, whichever is soonest.
You should be able to commit to being tested weekly for the duration of Autumn Quarter; however, those who will be away from campus periodically during the quarter are still eligible to be tested during the weeks that they are on campus. You can request make-up tests, changes to your test schedule, or opt-out at the test site or by contacting C19Testing@uchicago.edu.
The testing program operates in the Walker Museum, Suite 309, located on the main quadrangle at 1115 E. 58th Street. It will also operate Fridays at Chicago Booth’s downtown Gleacher Center location, in room 101. The Walker Museum test site can be accessed via the ground-level entrance located between Rosenwald Hall and the Walker Museum. Participants can take the elevator or stairs to the third floor, then turn left and continue down the hallway to enter the test site.
No additional parking will be designated for the testing locations.
Testing appointments will be set for specific times. (This is different from the 4-hour testing windows used last year.) Participants will be able to change their testing appointment day and time via self-service capabilities in the testing portal, subject to appointment availability. If you are unable to be tested at your regular appointment time, you must contact the testing program at C19Testing@uchicago.edu or reschedule through the portal, subject to testing availability.
All testing locations have been carefully reviewed by the UCM and University Facilities Services teams to ensure that proper social distancing, ventilation, and privacy. Specimen collection is expected to take no more than 10 minutes, and proper PPE will be required at all testing locations by the testing program staff, as appropriate. Screenings will take place at scheduled timeframes to help control density.
All costs for administering the Voluntary Surveillance Testing Program are covered by the University with no cost to participants. Insurance information will not be requested or required.
Yes. While the test should only take about 10 minutes each week, the time for the test as well as time getting to and from the testing location will be considered part of employees’ paid time. Employees who are part of the voluntary testing program should notify their managers of their testing schedule test to arrange for any necessary coverage.
The test is a self-performed saliva test. Members of the COVID-19 Testing team will be present to assist with medical questions and verify samples after collection. Specimens are transported to a third-party laboratory for processing and reporting of results.
If you test positive, your participation in the Voluntary Surveillance Testing Program will be paused for 90 days.If you are scheduled to participate in the Voluntary Surveillance Testing Program, and you have tested positive for COVID-19 at any point in the 90 days prior to the day you are scheduled for your first test in the UChicago program, you should provide such evidence to the attention of C19Testing@uchicago.edu.
There will likely be enrollment opportunities at the start of Winter and Spring quarters, provided you meet the program’s requirements, listed above.
SYMPTOMATIC & EXPOSURE TESTING PROGRAM
The University can provide testing to members of the UChicago community who have symptoms or have had close contact with someone who tested positive for COVID-19. Testing is conducted through the UChicago COVID-19 Symptomatic & Exposure Testing Program and uses a Nucleic Acid Amplification (NAAT) real-time reverse transcription polymerase chain reaction (RT-PCR) test.
Symptomatic Testing will take place on the Hyde Park campus, in Stuart Hall, Suite 007 (lower level in the former Stuart Hall Café), located on the main quadrangle at 5835 S. Greenwood Avenue). Appointments are available Monday through Friday from 9a.m. to 4p.m. Test results are available within two days.
Exposure Testing will take place at the Walker Museum test site, 1115 E. 58th St. Suite 309, on the Hyde Park campus’ main quadrangle. Appointments are available Monday through Friday from 8 a.m. to 4:45 p.m. Test results are available within two days.
Students and employees may schedule appointments via my.WellnessPortal.
Anyone not already enrolled in the UChicago COVID-19 Mandatory or Voluntary Surveillance Testing Programs must complete the voluntary consent form here prior to being tested.
All costs for administering the Symptomatic & Exposure Surveillance Testing Program are covered by the University with no cost to participants. Insurance information will not be requested or required.
The test is a self-performed saliva test. Members of the COVID-19 Testing team will be present to assist with questions and verify samples after collection. Specimens are transported to a third-party laboratory for processing and reporting of results.
Yes. After calling to be scheduled for a screening, you will be emailed consent and HIPAA authorization forms that you must sign in order to release your results to the University and to UCM.
Face Covering Information
Yes. A face covering that fits around the back of the head can still meet the requirements – it should fit snugly but comfortably against the side of the face and allow for breathing without restrictions. This requirement is not met by masks that are loose-fitting, such as neck gaiters, bandanas, or scarves.
No, masks with vents do not comply with University requirements, because the vents can let viral particles through.
According to the CDC, when supplies are available, individuals may choose to use a basic disposable N95 respirator for personal use, instead of a mask, in some situations. CDC recommends that special N95 respirators labeled as “surgical” or “medical” should be prioritized for healthcare providers.
The CDC has advised that KN95 masks can be preferable “in some situations or for some people.” This includes situations of prolonged close contact with people who do not live in the same household, or for people at increased risk for severe illness from COVID-19. Visit the CDC website for more information and guidance about KN95 masks.